Recent advances in defining the ubiquitylome

References

• Ben-Saadon R, Fajerman I, Ziv T, et al. The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminus. J Biol Chem 2004;279(4):41414-21
   PubMedGoogle Scholar
• Ciechanover A, Ben-Saadon R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol 2004;14(3):103-6
   PubMed Web of Science ®Google Scholar
• Cadwell K, Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005;309(5731):127-30
   PubMed Web of Science ®Google Scholar
• Wang X, Herr RA, Chua WJ, et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J Cell Biol 2007;177(4):613-24
   PubMed Web of Science ®Google Scholar
• Wang X, Herr RA, Hansen TH. Ubiquitination of substrates by esterification. Traffic 2012;13(1):19-24
   PubMed Web of Science ®Google Scholar
• Anania VG, Bustos DJ, Lill JR, et al. A novel peptide-based SILAC method to identify the posttranslational modifications provides evidence for unconventional ubiquitination in the ER-associated degradation pathway. Int J Proteomics 2013;2013:857918
   PubMedGoogle Scholar
• Ciechanover A, Stanhill A. The complexity of recognition of ubiquitinated substrates by the 26S proteasome. Biochim Biophys Acta 2014;1843(1):86-9
   PubMed Web of Science ®Google Scholar
• Iwai K, Tokunaga F. Linear polyubiquitination: a new regulator of NF-κB activation. EMBO Rep 2009;10(7):706-13
   PubMed Web of Science ®Google Scholar
• Dammer EB, Na CH, Xu P. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer Disease. J Biol Chem 2011;286:10457-65
   PubMed Web of Science ®Google Scholar
• Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol Cell 2006;24(5):701-11
   PubMed Web of Science ®Google Scholar
• Komander D, Rape M. The ubiquitin code. Annu Rev Biochem 2012;81:203-29
   PubMed Web of Science ®Google Scholar
• Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-33
   PubMed Web of Science ®Google Scholar
• Van Wijk SJL, Timmers HTM. The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J 2009;24(4):981-93
   PubMed Web of Science ®Google Scholar
• McGrath JP, Jentsch S, Varshavsky A. UBA 1: an essential yeast gene encoding ubiquitin-activating enzyme. EMBO J 1991;10(1):227-36
   PubMed Web of Science ®Google Scholar
• Finley D, Ulrich HD, Sommer T, Kaiser P. The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics 2012;192:319-60
   PubMed Web of Science ®Google Scholar
• Starita LM, Lo RS, Eng JK, et al. Sites of ubiquitin attachment in Saccharomyces cerevisiae. Proteomics 2012;12(2):236-40
   PubMed Web of Science ®Google Scholar
• Low TY, Magliozzi R, Guardavaccaro D, Heck AJ. Unraveling the ubiquitin-regulated signaling networks by mass spectrometry-based proteomics. Proteomics 2013;13(3-4):526-37
   PubMed Web of Science ®Google Scholar
• Zacksenhaus E, Sheinin R. Molecular cloning, primary structure and expression of the human X linked A1S9 gene cDNA which complements the ts AS9 mouse L cell defect in DNA replication. EMBO J 1990;9(9):2923-9
   PubMed Web of Science ®Google Scholar
• Semple CA; Riken Ger Group, GSL Members. The comparative proteomics of ubiquitination in mouse. Genome Res 2003;13(6B):1389-94
   PubMed Web of Science ®Google Scholar
• Claque MJ, Coulson JM, Urbé S. Cellular functions of the DUBs. J Cell Sci 2012;125:277-86
   PubMed Web of Science ®Google Scholar
• Mosesson Y, Chetrit D, Schley L, et al. Monoubiquitylation regulates endosomal localization of Lst2, a negative regulator of EGF receptor signaling. Dev Cell 2009;16(5):687-98
   PubMed Web of Science ®Google Scholar
• Sussamn RT, Stanek TJ, Esteso P, et al. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2). J Biol Chem 2013;288:24234-46
   PubMed Web of Science ®Google Scholar
• Husnjak K, Dikic I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 2012;81:291-322
   PubMed Web of Science ®Google Scholar
• Meierhofer D, Wang X, Huang L, Kaiser P. Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. J Proteome Res 2008;7(10):4566-76
   PubMed Web of Science ®Google Scholar
• Xu P, Duong DM, Seyfried NT, et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009;137(1):133-45
   PubMed Web of Science ®Google Scholar
• Kim W, Bennett EJ, Huttlin EL, et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 2011;44(2):325-40
   PubMed Web of Science ®Google Scholar
• Jung JW, Bae SJ, Kang GY, et al. Analysis of the biochemical role of Lys-11 in polyubiquitin chain formation using quantitative mass spectrometry. Rapid Commun Mass Spectrom 2013;27(2):339-46
   PubMed Web of Science ®Google Scholar
• Behrends C, Harper JW. Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol 2011;18:520-8
   PubMed Web of Science ®Google Scholar
• Matsumoto ML, Wickliffe KE, Dong KC, et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 2010;39(3):477-84
   PubMed Web of Science ®Google Scholar
• Williamson A, Wickliffe KE, Mellone BG, et al. Identification of a physiological E2 module for the human anaphase-promoting complex. Proc Natl Acad Sci USA 2009;106(43):18213-17
   PubMed Web of Science ®Google Scholar
• Dynek JN, Goncharov T, Dueber EC, et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signaling. EMBO J 2010;29(24):4198-209
   PubMed Web of Science ®Google Scholar
• Spence J, Sadis S, Haas AL, Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol 1995;15(3):1265-73
   PubMed Web of Science ®Google Scholar
• Huang F, Kirkpatrick D, Jiang X, et al. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Mol Cell 2006;21(6):737-48
   PubMed Web of Science ®Google Scholar
• Wu-Baer F, Lagrazon K, Yuan W, Baer R. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J Biol Chem 2003;278(37):34743-6
   PubMed Web of Science ®Google Scholar
• de Bie P, Zaaroor-Regev D, Ciechanover A. Regulation of the Polycomb protein RING1B ubiquitination by USP7. Biochem Biophys Res Commun 2010;400(3):389-95
   PubMed Web of Science ®Google Scholar
• Johnson ES, Ma PC, Ota IM, Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem 1995;270(29):17442-56
   PubMed Web of Science ®Google Scholar
• Pickart CM. Ubiquitin in chains. Trends Biochem Sci 2000;25(11):544-8
   PubMed Web of Science ®Google Scholar
• Hershko A, Ciechanover A. The Ubiquitin System. Annu Rev Biochem 1998;67:425-79
   PubMed Web of Science ®Google Scholar
• Emmerich CH, Schmukle AC, Walczak H. The emerging role of linear ubiquitination in signaling. Sci Signal 2011;4(204):re5
   PubMed Web of Science ®Google Scholar
• Gerlach B, Cordier SM, Schmukle AC, et al. Linear ubiquitination prevents inflammation and regulates immune signaling. Nature 2011;471(7340):591-6
   PubMed Web of Science ®Google Scholar
• Xu G, Paige JS, Jaffrey SR. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat Biotech 2010;28:868-73
   PubMed Web of Science ®Google Scholar
• Peng J, Schwartz D, Elias JE, et al. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 2003;21:921-6
   PubMed Web of Science ®Google Scholar
• Danielsen JM, Sylvestersen KB, Bekker-Jensen S, et al. Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics 2011;10(3):M110.003590
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu P, Inuzuka H, Wei W. Roles of F-box proteins in cancer. Nat Rev Cancer 2014;14:233-47
   PubMed Web of Science ®Google Scholar
• Cuanalo-Contreras K, Mukherjee A, Soto C. Role of protein misfolding and proteostasis in protein misfolding diseases and gaining. Int J Cell Biol 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Bellavista E, Santoro A, Galimberti D, et al. Current understand on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis. Autoimmune Dis 2014;2014:739705
   PubMedGoogle Scholar
• Jung T, Catalgol B, Grune T. The proteasomal system. Mol Aspects Med 2009;30(4):191-296
   PubMed Web of Science ®Google Scholar
• Kessler BM. Ubiquitin–omics reveals novel networks and associations with human disease. Curr Opin Chem Biol 2013;17(1):59-65
   PubMed Web of Science ®Google Scholar
• Satija YK, Bhardwaj A, Das S. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer. Int J Cancer 2013;133(12):2759-68
   PubMed Web of Science ®Google Scholar
• Shi D, Grossman SR. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets. Cancer Biol Ther 2010;10(8):737-47
   PubMed Web of Science ®Google Scholar
• Weekes J, Morrison K, Mullen A, et al. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 2003;3(2):208-16
   PubMed Web of Science ®Google Scholar
• Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev 2011;91(4):1161-218
   PubMed Web of Science ®Google Scholar
• Sarraf SA, Raman M, Guarani-Pereira V, et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 2013;496(7445):372-6
   PubMed Web of Science ®Google Scholar
• Lücking CB, Dürr A, Bonifati V, et al. Association between early-onset Parkinson’s disease and mutations in the Parkin gene. N Engl J Med 2000;342:1560-7
   PubMed Web of Science ®Google Scholar
• Cookson MR, Lockhart PJ, McLendon C, et al. RING finger 1 mutations in Parkin produce altered localization of the protein. Hum Mol Genet 2003;12(22):2957-65
   PubMed Web of Science ®Google Scholar
• Chan NC, Salazar AM, Pham AH, et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 2011;20(9):1726-37
   PubMed Web of Science ®Google Scholar
• Wang F, Durfee LA, Huibregtse JM. A cotranslational ubiquitination pathway for quality control of misfolded proteins. Mol Cell 2013;50(3):368-78
   PubMed Web of Science ®Google Scholar
• Levine CG, Mitra D, Sharma A, et al. The efficiency of protein compartmentalization into the secretory pathway. Mol Biol Cell 2005;16:279-91
   PubMed Web of Science ®Google Scholar
• Balch WE, Morimoto A, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science 2008;319:916-19
   PubMed Web of Science ®Google Scholar
• Morimoto RI. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 2008;22:1427-38
   PubMed Web of Science ®Google Scholar
• Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011;475:324-32
   PubMed Web of Science ®Google Scholar
• Duttler S, Pechmann S, Frydman J. Principles of cotranslational ubiquitination and quality control at the ribosome. Mol Cell 2013;50(3):379-93
   PubMed Web of Science ®Google Scholar
• Baer R, Ludwig T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr Opin Genet Dev 2002;12(1):86-91
   PubMed Web of Science ®Google Scholar
• Wu W, Koike A, Takeshita T, Ohta T. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div 2008;3:1
   PubMed Web of Science ®Google Scholar
• Song M, Hakala K, Weintraub ST, Shiio Y. Quantitative proteomic identification of the BRCA1 ubiquitination substrates. J Proteome Res 2011;10(11):5191-8
   PubMed Web of Science ®Google Scholar
• Thakar A, Parvin J, Zlatanova J. BRCA1/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle. J Biomol Struct Dyn 2010;27(4):399-406
   PubMed Web of Science ®Google Scholar
• Hashizume R, Fukuda M, Maeda I, et al. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 2001;276:14534-40
   Web of Science ®Google Scholar
• Claque MJ, Barsukov I, Coulson JM, et al. Deubiquitylases from genes to organism. Physiol Rev 2013;93(3):1289-315
   PubMed Web of Science ®Google Scholar
• Swaney DL, Beltrao P, Starita L, et al. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Nat Methods 2013;10(7):676-82
   PubMed Web of Science ®Google Scholar
• Hess S. The emerging field of chemo- and pharmacoproteomics. Proteomics Clin Appl 2013;7(1-2):171-80
   PubMed Web of Science ®Google Scholar
• Hitchcock AL, Auld K, Gygi SP, Silver PA. A subset of membrane-associated proteins is ubiquitinated in response to mutations in the endoplasmic reticulum degradation machinery. Proc Natl Acad Sci USA 2003;100(22):12735-40
   PubMed Web of Science ®Google Scholar
• Kirkpatrick DS, Weldon SF, Tsapralis G, et al. Proteomic identification of ubiquitinated proteins from human cells expressing His-tagged ubiquitin. Proteomics 2005;5(8):2104-11
   PubMed Web of Science ®Google Scholar
• Jeon HB, Choi ES, Yoon JH, et al. A proteomics approach to identify the ubiquitinated proteins in mouse heart. Biochem Biophys Res Commun 2007;357(3):731-6
   PubMed Web of Science ®Google Scholar
• Tagwerker C, Flick K, Cui M, et al. A tandem affinity tag for two-step purification under fully denaturing conditions: application in ubiquitin profiling and protein complex identification combined with in vivo cross-linking. Mol Cell Proteomics 2006;5(4):737-48
   PubMed Web of Science ®Google Scholar
• Kim DY, Scalf M, Smith LM, Vierstra RD. Advanced proteomic analyses yield a deep catalog of ubiquitylation targets in Arabidopsis. Plant Cell 2013;25(5):1523-40
   PubMed Web of Science ®Google Scholar
• Mayor T, Lipford JR, Graumann J, et al. Analysis of polyubiquitin conjugates reveals that the Rpn10 substrate receptor contributes to the turnover of multiple proteasome targets. Mol Cell Proteomics 2005;4(6):741-51
   PubMed Web of Science ®Google Scholar
• Tan F, Lu L, Cai Y. Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells. Proteomics 2008;8(14):2885-96
   PubMed Web of Science ®Google Scholar
• Manzano C, Abraham Z, López-Torrejón G, Del Pozo JC. Identification of ubiquitinated proteins in Arabidopsis. Plant Mol Biol 2008;68(1-2):145-58
   PubMed Web of Science ®Google Scholar
• Maor R, Jones A, Nuhse TS, et al. Multidimensional protein identification technology (MudPIT) analysis of ubiquitinated proteins in plants. Mol Cell Proteomics 2007;6:601-10
   PubMed Web of Science ®Google Scholar
• Wolters DA, Washburn MP, Yates JR 3rd. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 2001;73(23):5683-90
   PubMed Web of Science ®Google Scholar
• Shi Y, Chan DW, Jung SY, et al. A data set of human endogenous protein ubiquitination sites. Mol Cell Proteomics 2011;10(5):M110.002089
   PubMed Web of Science ®Google Scholar
• Vasilescu J, Smith JC, Ethier M, Figeys D. Proteomic analysis of ubiquitinated proteins from human MCF-7 breast cancer cells by immunoaffinity purification and mass spectrometry. J Proteome Res 2005;4(6):2192-200
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Hatekeyama S, Oyamada K, et al. Large-scale analysis of the human ubiquitin-related proteome. Proteomics 2005;5(16):4145-51
   PubMed Web of Science ®Google Scholar
• Goldknopf IL, Busch H. Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24. Proc Natl Acad Sci USA 1977;74:864-8
   PubMed Web of Science ®Google Scholar
• Anania VG, Pham VC, Huang X, et al. Peptide level immunoaffinity enrichment enhances ubiquitination site identification on individual proteins. Mol Cell Proteomics 2014;13(1):145-56
   PubMed Web of Science ®Google Scholar
• Udeshi ND, Mertins P, Svinkina T, Carr SA. Large-scale identification of ubiquitination sites by mass spectrometry. Nat Protoc 2013;8(10):1950-60
   PubMed Web of Science ®Google Scholar
• Wagner SA, Beli P, Weinert BT, et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics 2011;10(10):M111.013284
   PubMed Web of Science ®Google Scholar
• Lee KA, Hammerle LP, Andrews PS, et al. Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem 2011;286:41530-8
   PubMed Web of Science ®Google Scholar
• Emanuele MJ, Elia AEH, Xu Q, et al. Global identification of modular Cullin-RING ligase substrates. Cell 2011;147(2):459-74
   PubMed Web of Science ®Google Scholar
• Bustos D, Bakalarski CE, Yang Y, et al. Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment. Mol Cell Proteomics 2012;11(12):1529-40
   PubMed Web of Science ®Google Scholar
• Na CH, Jones DR, Yang Y, et al. Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. J Proteome Res 2012;11(9):4722-32
   PubMed Web of Science ®Google Scholar
• Udeshi ND, Mani DR, Eisenhaure T, et al. Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Mol Cell Proteomics 2012;11:148-59
   PubMed Web of Science ®Google Scholar
• Udeshi ND, Svinkina T, Mertins P, et al. Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Mol Cell Proteomics 2013;12(3):825-31
   PubMed Web of Science ®Google Scholar
• Goldberg AL. Development of proteasome inhibitors as research tools and cancer drugs. J Cell Biol 2012;199(4):583-8
   PubMed Web of Science ®Google Scholar
• Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001;8(8):739-58
   PubMed Web of Science ®Google Scholar
• Myung J, Kim KB, Crews CM. The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev 2001;21:45-273
   Web of Science ®Google Scholar
• Rentsch A, Landsberg D, Brodmann T, et al. Synthesis and pharmacology of proteasome inhibitors. Angew Chem Int Ed Engl 2013;52(21):5450-88
   PubMed Web of Science ®Google Scholar
• Zhou J, Bi D, Lin Y, et al. Shotgun proteomics and network analysis of ubiquitin-related proteins from human breast carcinoma epithelial cells. Mol Cell Biochem 2012;359(1-2):375-84
   PubMed Web of Science ®Google Scholar
• Collins GA, Gomez TA, Deshaies RJ, Tansey WP. Combined chemical and genetic approach to inhibit proteolysis by the proteasome. Yeast 2010;27(11):965-74
   PubMed Web of Science ®Google Scholar
• Pandit B, Gartel AL. Proteasome inhibitors induce p53-independent apoptosis in human cancer cells. Am J Pathol 2011;178(1):355-60
   PubMed Web of Science ®Google Scholar
• Guo N, Peng Z. MG132, a proteasome inhibitor, induces apoptosis in tumor cells. Asia Pac J Clin Oncol 2013;9(1):6-11
   PubMed Web of Science ®Google Scholar
• Crawford LJ, Irvine AE. Targeting the ubiquitin proteasome system in hematological malignancies. Blood Rev 2013;27(6):297-304
   PubMed Web of Science ®Google Scholar
• Loeffler-Ragg J, Mueller D, Gamerith G, et al. Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib. Mol Cancer Ther 2009;8(7):1995-2006
   PubMed Web of Science ®Google Scholar
• Mertins P, Qiao JW, Patel J, et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 2013;10(7):634-7
   PubMed Web of Science ®Google Scholar
• Moreau P. The emerging role of carfilzomib combination therapy in the management of multiple myeloma. Expert Rev Hematol 2014;7(2):265-90
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang J, Kirk C, et al. Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib. Drug Metab Dispos 2013;41(1):230-7
   PubMed Web of Science ®Google Scholar
• Zhang W, Sidhu SS. Development of inhibitors in the ubiquitination cascade. FEBS Lett 2014;588(2):356-67
   PubMed Web of Science ®Google Scholar
• Cannon J, Nakasone M, Fushman D, Fenselau C. Proteomic identification and analysis of K63-linked ubiquitin conjugates. Anal Chem 2012;84(22):10121-8
   PubMed Web of Science ®Google Scholar
• Sobott F, Watt SJ, Smith J, et al. Comparison of CID versus ETD based MS/MS fragmentation for the analysis of protein ubiquitination. J Am Soc Mass Spectrom 2009;20(9):1652-9
   PubMed Web of Science ®Google Scholar
• Lopitz-Otsoa F, Rodriguez-Suarez E, Aillet F. Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBESs). J Proteomics 2012;75(10):2998-3014
   PubMed Web of Science ®Google Scholar
• Sylvestersen KB, Young C, Nielsen ML. Advances in characterizing ubiquitylation sites by mass spectrometry. Curr Opin Chem Biol 2013;17:49-58
   PubMed Web of Science ®Google Scholar
• Xu G, Jaffrey SR. Comprehensive profiling of protein ubiquitination for drug discovery. Curr Pharm Des 2013;19(18):3315-28
   PubMed Web of Science ®Google Scholar
• Polge C, Uttenweiler-Joseph S, Leulmi R, et al. Deciphering the ubiquitin proteome: limits and advantages of high throughput global affinity purification-mass spectrometry approaches. Int J Biochem Cell Biol 2013;45(10):2136-46
   PubMed Web of Science ®Google Scholar